Evidence map›Paper›PMID 42574715›Full record

Observational studyExperimental physiology2026

Clinical and biochemical factors associated with insulin therapy in gestational diabetes: The role of OGTT-based groups.

Libera Troìa, Martina Garassino, Riccardo Bertinato, Caroline Leitao Thomaz, Giulia Turatello, Chiara Airoldi, Alessandro Libretti, Daniela Surico, Valentino Remorgida

Abstract readObservational Study
In one paragraph

Observational study in Experimental physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Libera TroìaDepartment of Gynaecology and Obstetrics, University Hospital Maggiore della Carità, Novara, Italy.
Martina GarassinoDepartment of Gynaecology and Obstetrics, University Hospital Maggiore della Carità, Novara, Italy.
Riccardo BertinatoDepartment of Gynaecology and Obstetrics, University Hospital Maggiore della Carità, Novara, Italy.
Caroline Leitao ThomazDepartment of Gynaecology and Obstetrics, University Hospital Maggiore della Carità, Novara, Italy.
Giulia TuratelloDepartment of Gynaecology and Obstetrics, University Hospital Maggiore della Carità, Novara, Italy.
Chiara AiroldiDepartment of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
Alessandro LibrettiDepartment of Gynaecology and Obstetrics, University Hospital Maggiore della Carità, Novara, Italy.ORCID https://orcid.org/0000-0001-8478-5471
Daniela SuricoDepartment of Gynaecology and Obstetrics, University Hospital Maggiore della Carità, Novara, Italy.
Valentino RemorgidaDepartment of Gynaecology and Obstetrics, University Hospital Maggiore della Carità, Novara, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gestational diabetes mellitus (GDM) represents one of the most common metabolic disorders of pregnancy. This study aimed to identify clinical and biochemical factors associated with antenatal insulin therapy, focusing on the association with oral glucose tolerance test (OGTT)-based phenotypes. Retrospective observational study among GDM women, divided according to their treatment (nutritional therapy (NT) or insulin therapy). GDM was classified into three phenotypes based on OGTT results: isolated fasting hyperglycaemia (IFH-GDM), isolated post-load hyperglycaemia (IPH-GDM) and combined hyperglycaemia (CH-GDM). Maternal demographic, obstetric and biochemical data were analysed. Multivariable logistic regression analysis was performed to identify factors independently associated with insulin therapy. Among 458 women, 39.3% required insulin therapy. Independent factors associated with the use of insulin therapy included pre-pregnancy obesity (odds ratio (OR) 2.07, 95% CI: 1.21-3.55), spontaneous miscarriage history (OR 1.89, 95% CI: 1.21-2.93), pregestational hypothyroidism (OR 2.63, 95% CI: 1.08-6.42), GDM diagnosis at 24-28 weeks versus earlier diagnosis (OR 0.45, 95% CI: 0.28-0.72), and GDM phenotype. Compared with IFH-GDM, IPH-GDM was associated with a lower risk of insulin therapy (OR 0.51, 95% CI: 0.31-0.84), whereas CH-GDM was associated with a higher risk (OR 1.90, 95% CI: 1.10-3.31). In conclusion, women with fasting and combined hyperglycaemia represent the highest-risk group for insulin therapy. Integrating OGTT-based phenotypes with clinical risk factors was associated with increased likelihood of insulin therapy requirement and may support individualized clinical assessment.

Indexed as

Diabetes, GestationalInsulinAdultBlood GlucoseFemaleGlucose Tolerance TestHumansHyperglycemiaHypoglycemic AgentsPregnancyRetrospective StudiesRisk FactorsBlood GlucoseHypoglycemic AgentsInsulinantenatal careGDMgestational diabetesinsulin therapynutritional therapyOGTTphenotypes

Identifiers

PMID42574715
PMCPMC13456692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.